Keywords: british, biotech, kept, afloat, new, marimastat, data

British Biotech kept afloat by new marimastat data in gastric cancer

Article | 25 August 1999

Print This

Beleaguered UK firm British Biotech has seen its shares jump almostone-third on the back of new data from a Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in